NASDAQ: MAZE Maze Therapeutics, Inc. 8-K

Maze Therapeutics reports Q1 2026 financial results

Filed May 12, 2026 · Period ending May 12, 2026 · ~1 min read

1 material change detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade MAZE commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 1, 2026 6:17 PM